These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31897228)

  • 1. Integrin-Linked Kinase Is Involved In the Proliferation and Invasion of Esophageal Squamous Cell Carcinoma.
    Ning Z; Zhu X; Jiang Y; Gao A; Zou S; Gu C; He C; Chen Y; Ding WQ; Zhou J
    J Cancer; 2020; 11(2):324-333. PubMed ID: 31897228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin-linked kinase affects the sensitivity of esophageal squamous cell carcinoma cells to chemotherapy with cisplatin via the Wnt/beta-catenin signaling pathway.
    Xu T; Ma XL; Wei Y; Cao LY; Gao Y; Liu J; Zhang L
    Bioengineered; 2022 May; 13(5):12532-12547. PubMed ID: 35587162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
    Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
    Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma.
    Yu H; Yao J; Du M; Ye J; He X; Yin L
    Oncol Lett; 2020 Jan; 19(1):542-548. PubMed ID: 31897169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
    Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
    J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.
    Zeng YZ; Zhang YQ; Chen JY; Zhang LY; Gao WL; Lin XQ; Huang SM; Zhang F; Wei XL
    Front Oncol; 2021; 11():627713. PubMed ID: 33854967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated proteomics and phosphoproteomics analyses of esophageal cancer cells with different invasive abilities.
    Xu N; Lai C; He QM; Cai Y; Yu H; Zhong W; Chen S; Wu FC; Chen H
    Life Sci; 2023 Nov; 332():122078. PubMed ID: 37734435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
    Koul D; Shen R; Bergh S; Lu Y; de Groot JF; Liu TJ; Mills GB; Yung WK
    Mol Cancer Ther; 2005 Nov; 4(11):1681-8. PubMed ID: 16275989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
    Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
    J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma.
    Ma XL; Yao H; Wang X; Wei Y; Cao LY; Zhang Q; Zhang L
    Oncol Lett; 2019 Oct; 18(4):4114-4125. PubMed ID: 31579417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma.
    Liu Z; Yu S; Ye S; Shen Z; Gao L; Han Z; Zhang P; Luo F; Chen S; Kang M
    J Proteomics; 2020 Jan; 211():103557. PubMed ID: 31669361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
    Liang Y; Li S
    Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling.
    Hao WW; Xu F
    World J Gastrointest Oncol; 2022 Jul; 14(7):1239-1251. PubMed ID: 36051093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
    Zhu ZQ; Hu HF; Zheng XY; Wang F
    Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
    [No Abstract]   [Full Text] [Related]  

  • 17. ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway.
    Huang W; Zhu J; Shi H; Wu Q; Zhang C
    Onco Targets Ther; 2021; 14():3583-3596. PubMed ID: 34113124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma.
    Liu J; Ma X; Cao L; Wei Y; Gao Y; Qu C; Maimaitiming N; Zhang L
    J Oncol; 2022; 2022():3658334. PubMed ID: 36618074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minichromosome maintenance 6 complex component identified by bioinformatics analysis and experimental validation in esophageal squamous cell carcinoma.
    Li X; Ren Z; Xiong C; Geng J; Li Y; Liu C; Ren C; Liu H
    Oncol Rep; 2020 Sep; 44(3):987-1002. PubMed ID: 32583000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.